InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Chen Hongming. Director active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €105k. History available since 28 June 2021. The latest transaction was filed on 26 October 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
Chen Hongming is a director at Kala Pharmaceuticals, Inc.